Patient‐based prediction algorithm of relapse after allo‐HSCT for acute Leukemia and its usefulness in the decision‐making process using a machine learning approach

Although allogeneic hematopoietic stem cell transplantation (allo‐HSCT) is a curative therapy for high‐risk acute leukemia (AL), some patients still relapse. Since patients simultaneously have many prognostic factors, difficulties are associated with the construction of a patient‐based prediction al...

Descripción completa

Detalles Bibliográficos
Autores principales: Fuse, Kyoko, Uemura, Shun, Tamura, Suguru, Suwabe, Tatsuya, Katagiri, Takayuki, Tanaka, Tomoyuki, Ushiki, Takashi, Shibasaki, Yasuhiko, Sato, Naoko, Yano, Toshio, Kuroha, Takashi, Hashimoto, Shigeo, Furukawa, Tatsuo, Narita, Miwako, Sone, Hirohito, Masuko, Masayoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718546/
https://www.ncbi.nlm.nih.gov/pubmed/31305031
http://dx.doi.org/10.1002/cam4.2401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718546/
https://www.ncbi.nlm.nih.gov/pubmed/31305031
http://dx.doi.org/10.1002/cam4.2401

Ejemplares similares